MARKET TRENDS: Stay Profitable And Protected With This Routine Shares of Ligand Pharmaceuticals (LGND) are absolutely flying, up almost 88% this year, as investors line up behind the company's unique royalty-based business model. Ligand Pharma is a biotech company that doesn't make biologic medicines. Instead, it makes deals. The company has a portfolio of more than 90 partnered commercial and development-stage drugs, including treatments for cancer, kidney disease, diabetes,… Related news Drug Giant Merck ...

Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make cancer treatments, as part of its pledge to invest billions into building U.S. s... ...

So what most people realize is, you know, there's amazing cell and gene therapies coming through in the market at the moment and they're done and actuated in different ways. Uh crisper gene editing is a way in which you can make very precise edits to a patient's DNA. And what that allows you to do is identify new targets, but also to correct some diseases, more importantly expand the number of treatable diseases.And we're working with our partners. We've built the world's most powerful crisper gene editing ...